FindTrial
Sign In

Clinical, molecular, genic and phenotypic characterization of gastric adenosquamous carcinoma and esophageal adenosquamous carcinoma

Clinical, molecular, genic and phenotypic characterization of gastric adenosquamous carcinoma and esophageal adenosquamous carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082844
Enrollment
Unknown
Registered
2024-04-09
Start date
2023-08-07
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach cancer, esophageal cancer

Interventions

Gastric adenosquamous carcinoma group:None
Esophageal adenosquamous carcinoma group:None

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years old 2. Gastric adenosquamous carcinoma was confirmed by major pathological examination after gastrectomy (the ratio of adenocarcinoma to squamous carcinoma was >1/3) or esophageal adenosquamous carcinoma (=20% tissue composition for both squamous carcinoma and adenocarcinoma) 3. Complete clinical data, pathological data and follow-up information 4. The survival rate of patients who underwent radical surgery was greater than 1 month

Exclusion criteria

Exclusion criteria: Patient information is seriously incomplete

Design outcomes

Primary

MeasureTime frame
Pathological report;—

Countries

China

Contacts

Public ContactWenbin Yu

Qilu Hospital of Shandong University

wenbin_yu2003@163.com+86 185 6008 5155

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026